Search results for: Determining Value
Filter search results
Mata Charokopou – 2022 Prize Finalist
18 January 2023
Mata Charokopou, PharmD, MSc, Senior Director – Head of Global Payer Strategy & Health Economics in UCB. She is responsible for the development of evidence generation strategies, patient value strategy…
25 Years of the Cost Effectiveness Acceptability Curve
30 December 2019
…meaningful way – with the uncertainty inherent in cost-effectiveness calculations. Uncertainty means decision makers may make wrong decisions – adopt a technology which turns out not to be good value…
Mikel Berdud
26 February 2015
Mikel Berdud is an economist specialised in pharmaceutical R&D incentives, pricing and reimbursement, and social value of innovation. He holds a PhD in the topic of economics of organizations and…
Previews of Forthcoming Publications
27 July 2011
…One on access to drugs and vaccines in developing countries and the other on measuring value with pharmacoeconomics. OHE is making available as Occasional Papers drafts of two important chapters…
Applying a Multi-criteria Decision Analysis (MCDA) Approach to Elicit Stakeholders’ Preferences in Italy. The Case of Obinutuzumab for Rituximab-Refractory Indolent Non-Hodgkin Lymphoma (iNHL)
1 December 2016
Published paper using MCDA to obtain preferences on decision criteria across three stakeholder groups (patients, clinicians and payers) in Italy and to assess the value of obinutuzumab for rituximab-refractory iNHL….
New Seminar Briefing: Is Pharmaceutical R&D Experiencing a Productivity Crisis?
14 June 2012
…of these global companies is highest. With respect to sales, “the market value of NMEs for European companies is far lower than the market value for US companies even after…
Around The World in HTAs: Thailand – An Ever-Evolving Policy Tool
9 September 2024
…the development of innovations by evaluating them at their developmental stages, scan and streamline the innovation process by identifying health needs and gaps and estimate and maximise their value early…
Spotlight on OHE: Development and Use of Measures of Health Worldwide
16 July 2012
…Netherlands, and the United States – and plans for EQ-5D-5L Value Sets studies in 2012 and beyond. At ISPOR, Nancy also presented two poster sessions that examined the EQ-5D’s use…
Around the World in HTAs: Kenya – Riding the Waves of Change
19 May 2025
…(2023)), and initiatives like the recently launched social health insurance scheme (SHI) aimed to provide accessible, affordable and quality health services to the population. The value of HTA is enshrined…